You are here

  • Home
  • Archive
  • Volume 75, Issue 1
  • MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study

Citation Tools

Article menu
Clinical and epidemiological research
Extended report
MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Peterfy C, Emery P, Tak PP, et al
MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study
Annals of the Rheumatic Diseases 2016;75:170-177.